Liposomal formulations composed of phospholipids with different unsaturation degrees, head groups and at different cholesterol content have been tested for the encapsulation of Peptide Nucleic Acid (PNA) oligomers. The best loading capability (177 μg, ER% = 87.2) was obtained for pure liposomes of phosphatidylglycerol (DOPG) with negatively charged head group. The insertion of a 10-20% of cholesterol in DOPG based liposomes provides a slight decrease (~160 μg) of the PNA loading. On the other hand, the cholesterol addition (20-30%) slows down the PNA's release (~27%) in fetal bovine serum from the liposomal formulation. Based on the encapsulation and the release properties, PEGylated DOPG liposomes with a percentage of cholesterol of 10-20% are the optimal formulation for the loading of PNA-a210.

The influence of liposomal formulation on the incorporation and retention of PNA oligomers / P. Ringhieri, C. Avitabile, M. Saviano, G. Morelli, A. Romanelli, A. Accardo. - In: COLLOIDS AND SURFACES. B, BIOINTERFACES. - ISSN 0927-7765. - 145(2016 Sep 01), pp. 462-469. [10.1016/j.colsurfb.2016.05.034]

The influence of liposomal formulation on the incorporation and retention of PNA oligomers

A. Romanelli
;
2016

Abstract

Liposomal formulations composed of phospholipids with different unsaturation degrees, head groups and at different cholesterol content have been tested for the encapsulation of Peptide Nucleic Acid (PNA) oligomers. The best loading capability (177 μg, ER% = 87.2) was obtained for pure liposomes of phosphatidylglycerol (DOPG) with negatively charged head group. The insertion of a 10-20% of cholesterol in DOPG based liposomes provides a slight decrease (~160 μg) of the PNA loading. On the other hand, the cholesterol addition (20-30%) slows down the PNA's release (~27%) in fetal bovine serum from the liposomal formulation. Based on the encapsulation and the release properties, PEGylated DOPG liposomes with a percentage of cholesterol of 10-20% are the optimal formulation for the loading of PNA-a210.
cholesterol; DOPG; formulation; liposome; peptide nucleic acid; drug compounding; Drug Delivery Systems; liposomes; P
Settore CHIM/03 - Chimica Generale e Inorganica
1-set-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
col sur accepted.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 808.46 kB
Formato Adobe PDF
808.46 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/547479
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact